20.12.2013 • NewsAgrochemistryCABB Groupfood industry

CABB forms joint venture in China

Germany's CABB and Jining Gold Power from Shandong province agreed to establish a joint venture for the production and marketing of high quality monochloroacetic acid (MCA) in Jining, Shandong province in the People's Republic of China.

MCA is an important chemical building block for the synthesis of a variety of products into the food, personal care and agrochemical industries.

"This Chinese joint venture is CABB's next major step towards strengthening its acetyls business in this important growth market and manifesting a global production footprint," commented Dr. Martin Wienkenhöver, CEO of CABB. "Jining Gold Power is a very strong partner who will supply the new venture with key raw materials and energies." Dr. Uwe Brunk, General Manager of CABB's Acetyls Business Unit, added, "The new joint venture will double its capacity for high-quality MCA in China in the near future. CABB will enable the joint venture to reach the next technology level and to establish a leading company for high-quality MCA in the Chinese market with an international sphere of activity."

The joint venture is set to take over the existing production facilities of Jinwei Huasheng Chemical, which currently produces 20,000 tons of MCA each year. CABB will be the majority partner with holding 67 % of the shares. The joint venture is scheduled to begin production of high-quality MCA very soon. In addition, the joint venture plans to more than double its high-quality MCA output by raising production by over 25,000 tons per annum.

 

Company

CABB Group GmbH

Otto-Volger-Straße 3c
65843 Sulzbach am Taunus

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.